InceptionR’s Amneal Pharmaceuticals AMRX Stock Holding History

InceptionR’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,017	Closed	-$261K	–	641
2026 Q1	$261K	Buy	+21,017	New	+$282K	0.06%	512
2025 Q3	–	Sell	-14,191	Closed	-$115K	–	661
2025 Q2	$115K	Buy	+14,191	New	+$107K	0.03%	606
2025 Q1	–	Sell	-41,921	Closed	-$332K	–	535
2024 Q4	$332K	Sell	41,921 -15,928	-28%	-$134K	0.07%	425
2024 Q3	$481K	Buy	57,849 +36,480	+171%	+$285K	0.12%	327
2024 Q2	$136K	Buy	+21,369	New	+$136K	0.04%	536

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

InceptionR's AMRX Position: Q2 2026 in Review

InceptionR sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 21,017 shares — an estimated $261K sold.

InceptionR first reported a position in AMRX in Q2 2024 and held it in 5 quarters. The position peaked at $481K in Q3 2024. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

InceptionR reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
InceptionR sold 21,017 Amneal Pharmaceuticals shares in Q2 2026, an estimated $261K.
InceptionR first reported a position in Amneal Pharmaceuticals in Q2 2024 and held it in 5 quarters.
InceptionR's Amneal Pharmaceuticals position peaked at $481K in Q3 2024.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.